Company Filing History:
Years Active: 2024-2025
Title: Aurelien Lorin: Innovator in Influenza Virus Research
Introduction: Aurelien Lorin is a prominent inventor based in Quebec, Canada. He has made significant contributions to the field of biotechnology, particularly in the production of modified influenza viral proteins in plants. His innovative work has led to advancements in the understanding and production of influenza virus-like particles.
Latest Patents: Aurelien holds two patents related to influenza virus hemagglutinin mutants. His latest patents describe methods for producing and increasing influenza virus-like particle (VLP) production in plants. These VLPs comprise modified influenza viral proteins, such as modified influenza hemagglutinin (HA). The HA protein may include an amino acid sequence with at least one substitution compared to the corresponding wildtype amino acid sequence. Additionally, his patents provide nucleic acids encoding the modified HA protein and methods for increasing the yield of VLP production in plants or plant cells.
Career Highlights: Aurelien is associated with Aramis Biotechnologies Inc., where he applies his expertise in biotechnology to develop innovative solutions for viral protein production. His work is crucial in the ongoing efforts to enhance vaccine production and improve public health responses to influenza outbreaks.
Collaborations: Throughout his career, Aurelien has collaborated with notable colleagues, including Pierre-Olivier Lavoie and Alain Doucet. These collaborations have fostered a productive research